Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Not Confirmed
Not Confirmed
26-27 September, 2024
Oligo Chemistry & Ther...Oligo Chemistry & Therapeutics 2024
Not Confirmed
Not Confirmed
27 September, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Industry Trade Show
Not Confirmed
26-27 September, 2024
Oligo Chemistry & Ther...Oligo Chemistry & Therapeutics 2024
Webinar
Not Confirmed
27 September, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
18 Sep 2024
// INDIANPHARMAPOST
https://www.indianpharmapost.com/news/suven-life-sciences-announces-positive-topline-results-from-phase-2-poc-signal-detection-open-label-study-of-ropanicant-16195
11 Mar 2023
// ECONOMIC TIMES
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/suven-life-sciences-breathes-new-life-into-drug-discovery-plans/articleshow/98554309.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
17 Aug 2021
// PHARMABIZ
26 Apr 2020
// INDIATODAY
https://www.indiatoday.in/india/story/massive-fire-at-pharma-company-building-in-hyderabad-1671365-2020-04-26
25 Feb 2020
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211038
12 Feb 2020
// Ashwin Mohan MONEYCONTROL
https://www.moneycontrol.com/news/business/companies/exclusive-suven-life-sciences-puts-demerged-crams-arm-on-the-block-engages-barclays-as-sale-adviser-4935121.html
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19397
Submission : 2006-04-29
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19336
Submission : 2006-04-07
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22825
Submission : 2009-06-01
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22752
Submission : 2009-04-30
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2019-12-09
Pay. Date : 2019-09-27
DMF Number : 34130
Submission : 2019-09-20
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19266
Submission : 2006-03-18
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26794
Submission : 2012-12-27
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19092
Submission : 2006-01-06
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2019-04-15
Pay. Date : 2019-02-19
DMF Number : 33330
Submission : 2018-12-13
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2019-10-29
Pay. Date : 2019-09-27
DMF Number : 20498
Submission : 2007-04-26
Status : Active
Type : II
Details:
SUVN-G3031 (samelisant), potent and selective histamine H3 receptor inverse agonist, is being developed for the treatment of excessive daytime sleepiness (EDS) in adult narcolepsy patients with and without cataplexy.
Lead Product(s): Samelisant
Therapeutic Area: Sleep Brand Name: SUVN-G3031
Study Phase: Phase IIProduct Type: Small molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable April 15, 2024
Lead Product(s) : Samelisant
Therapeutic Area : Sleep
Highest Development Status : Phase II
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Suven Life Sciences to Present phase-2 Results on Samelisant at AAN 2024
Details : SUVN-G3031 (samelisant), potent and selective histamine H3 receptor inverse agonist, is being developed for the treatment of excessive daytime sleepiness (EDS) in adult narcolepsy patients with and without cataplexy.
Brand Name : SUVN-G3031
Molecule Type : Small molecule
Upfront Cash : Not Applicable
April 15, 2024
Details:
SUVN-502 (masupirdine) is a novel, potent, pure, and orally active 5-HT6 receptor antagonist, it is being investigated as a potential therapy against alzheimer's disease.
Lead Product(s): Masupirdine,Donepezil,Memantine Hydrochloride
Therapeutic Area: Neurology Brand Name: SUVN-502
Study Phase: Phase IIProduct Type: Small molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable March 11, 2023
Lead Product(s) : Masupirdine,Donepezil,Memantine Hydrochloride
Therapeutic Area : Neurology
Highest Development Status : Phase II
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Suven Life Sciences Breathes New Life Into Drug Discovery Plans
Details : SUVN-502 (masupirdine) is a novel, potent, pure, and orally active 5-HT6 receptor antagonist, it is being investigated as a potential therapy against alzheimer's disease.
Brand Name : SUVN-502
Molecule Type : Small molecule
Upfront Cash : Not Applicable
March 11, 2023
Details:
SUVN-502 (Masupirdine), a lead clinical candidate having undergone phase 2 study on 564 patients for moderate Alzheimer’s disease without meeting primary end point.
Lead Product(s): Masupirdine,Donepezil,Memantine Hydrochloride
Therapeutic Area: Neurology Brand Name: SUVN-502
Study Phase: Phase IIProduct Type: Small molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable August 16, 2021
Lead Product(s) : Masupirdine,Donepezil,Memantine Hydrochloride
Therapeutic Area : Neurology
Highest Development Status : Phase II
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : SUVN-502 (Masupirdine), a lead clinical candidate having undergone phase 2 study on 564 patients for moderate Alzheimer’s disease without meeting primary end point.
Brand Name : SUVN-502
Molecule Type : Small molecule
Upfront Cash : Not Applicable
August 16, 2021
Inspections and registrations
ABOUT THIS PAGE
Suven Life Sciences Limited is a supplier offers 29 products (APIs, Excipients or Intermediates).
Find a price of Entacapone bulk with DMF, CEP offered by Suven Life Sciences Limited
Find a price of Tamsulosin bulk with DMF, CEP offered by Suven Life Sciences Limited
Find a price of 2-Bromo-1-2-Ethoxyphenoxy-Ethane bulk with DMF, JDMF offered by Suven Life Sciences Limited
Find a price of Methoxybenzenesulfonamide Hydrochloride bulk with DMF, JDMF offered by Suven Life Sciences Limited
Find a price of Aripiprazole bulk with DMF offered by Suven Life Sciences Limited
Find a price of Calcium Acetate bulk with DMF offered by Suven Life Sciences Limited
Find a price of Divalproex Sodium bulk with DMF offered by Suven Life Sciences Limited
Find a price of Doxofylline bulk with DMF offered by Suven Life Sciences Limited
Find a price of Fenoprofen Calcium bulk with DMF offered by Suven Life Sciences Limited
Find a price of Gabapentin bulk with DMF offered by Suven Life Sciences Limited
Find a price of Glycopyrronium Bromide bulk with DMF offered by Suven Life Sciences Limited
Find a price of Glycopyrronium Tosylate bulk with DMF offered by Suven Life Sciences Limited
Find a price of Imatinib Mesylate bulk with JDMF offered by Suven Life Sciences Limited
Find a price of Nitazoxanide bulk with DMF offered by Suven Life Sciences Limited
Find a price of Trientine Hydrochloride bulk with DMF offered by Suven Life Sciences Limited
Find a price of Chloroquine Phosphate bulk with DMF offered by Suven Life Sciences Limited
Find a price of Entacapone bulk with DMF offered by Suven Life Sciences Limited
Find a price of Lamotrigine bulk with DMF offered by Suven Life Sciences Limited
Find a price of Losartan Potassium bulk with DMF offered by Suven Life Sciences Limited
Find a price of Methyltyrosine bulk with DMF offered by Suven Life Sciences Limited
Find a price of Zolmitriptan bulk with DMF offered by Suven Life Sciences Limited
Find a price of Aciclovir bulk offered by Suven Life Sciences Limited
Find a price of Carprofen bulk offered by Suven Life Sciences Limited
Find a price of Iron Sucrose bulk offered by Suven Life Sciences Limited
Find a price of Penicillamine bulk offered by Suven Life Sciences Limited
Find a price of Rifapentine bulk offered by Suven Life Sciences Limited
Find a price of Sodium ferric gluconate bulk offered by Suven Life Sciences Limited
Find a price of Thiabendazole bulk offered by Suven Life Sciences Limited
Find a price of Thiamine Hydrochloride bulk offered by Suven Life Sciences Limited
LOOKING FOR A SUPPLIER?